Back to today’s briefing

Story perspectives

Breakthrough Rabies Vaccine Requires No Refrigeration, Expands Access

9/26/2025

22 4 Full Breakdown

Summary

Story summary

Researchers at CU Boulder developed rabies vaccine stable at 104°F for three months, removing refrigeration and expanding access.
Described as 'sapphire-coated Jolly Ranchers,' it requires a single injection and shows strong immune responses in animal studies.
VitriVax plans to commercialize, with human trials in two years; the platform could be adapted to human papillomavirus (HPV) and human immunodeficiency virus (HIV).

1 of 1

Story summary

Researchers at CU Boulder developed rabies vaccine stable at 104°F for three months, removing refrigeration and expanding access.
Described as 'sapphire-coated Jolly Ranchers,' it requires a single injection and shows strong immune responses in animal studies.
VitriVax plans to commercialize, with human trials in two years; the platform could be adapted to human papillomavirus (HPV) and human immunodeficiency virus (HIV).